Women's Sexual Health Gets a Major Upgrade: Two New Treatment Options Are Changing the Game

Two groundbreaking treatments are finally giving women evidence-based options for sexual health challenges that have been largely ignored by medicine for decades. A first-of-its-kind sildenafil cream designed specifically for women is now available by prescription, while a libido-enhancing pill has received expanded approval for post-menopausal women.

What Makes This Sildenafil Cream Different for Women?

DARE to PLAY™ Sildenafil Cream represents the first evidence-backed topical formulation using the same active ingredient found in Viagra, but specifically developed for women's anatomy and needs. Unlike existing products that rely heavily on marketing claims, this cream is supported by multiple clinical trials including a randomized placebo-controlled study with 200 women and their partners.

The topical application is designed to increase genital blood flow within 10-15 minutes and improve arousal sensations without systemic effects. "When Viagra was approved in 1998, it revolutionized sexual medicine for men. But for women, comparable progress on enhancing the natural arousal sensations has stalled for nearly three decades," said Sabrina Martucci Johnson, President and CEO of Daré Bioscience.

How Does the Expanded Libido Pill Work?

Addyi (flibanserin) received Food and Drug Administration (FDA) approval on December 15 to treat low sexual desire in post-menopausal women under age 65, expanding its original 2015 approval for pre-menopausal women. The pill works by addressing neurotransmitters like dopamine, norepinephrine, and serotonin in the brain, balancing them to stimulate sexual desire signals while suppressing inhibitory ones.

This expansion addresses a significant gap in care, as an estimated 20 million women in the United States experience challenges related to genital arousal, yet there were no FDA-approved therapeutics specifically for this need. The approval process highlighted ongoing disparities in sexual health research and treatment options between men and women.

What Other Innovations Are Emerging in Sexual Wellness?

Beyond these two breakthrough treatments, sexual wellness medicine is experiencing rapid advancement across multiple areas. Recent innovations include:

• Shockwave Therapy: Low-intensity extracorporeal shockwave therapy (LI-ESWT) uses sound waves to improve blood flow and stimulate tissue repair for erectile dysfunction treatment, with many patients reporting improved function within a month
• Bioidentical Hormone Pellets: Advanced hormone replacement therapy using pellets implanted under the skin offers more consistent hormone delivery over 3-6 months, with 95% of patients reporting satisfaction with results
• Melanocortin Receptor Agonists: A new class of medications targeting brain pathways associated with sexual desire has shown promise for individuals with low libido
• Combination Therapies: Research shows combining treatments like shockwave therapy with traditional medications results in 25% greater improvement compared to single treatments

The field is also embracing personalized medicine approaches, using genetic testing to determine how individuals respond to sexual health medications and creating customized hormone therapies based on individual profiles rather than one-size-fits-all treatments.

"As more women speak openly about their sexual health, the need for research-backed solutions has never been greater," said Dr. Irwin Goldstein, Director of San Diego Sexual Medicine and a founder of the International Society for the Study of Women's Sexual Health. The availability of these evidence-based treatments represents important progress toward closing persistent gender gaps in sexual medicine that have left women with limited options for far too long.